Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.020
-0.110 (-2.66%)
Nov 2, 2026, 3:16 PM EST - Market open

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $5.49M in the twelve months ending June 30, 2026, down -32.27% year-over-year. In the year 2025, Taysha Gene Therapies had annual revenue of $9.77M with 17.28% growth. That makes Taysha Gene Therapies the 39,672nd largest company in the world by revenue and 5,263rd in the United States.

Revenue (ttm)
$5.49M
Revenue Growth
-32.27%
P/S Ratio
241.18
Revenue / Employee
$55,404
Employees
99
Market Cap
1.31B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.77M1.44M17.28%
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

TSHA News

More News